Ipca Labs

75
Buy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,747.80
-11 (-0.63%)
BSENSE

Jul 31, 03:59 PM

BSE+NSE Vol: 2.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
8,939.00
7,705.00
6,244.00
5,829.00
5,419.00
4,648.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
29.00
Net Sales
8,939.00
7,705.00
6,244.00
5,829.00
5,419.00
4,619.00
Expenditure (Ex Depriciation)
Stock Adjustments
-46.00
-130.00
100.00
-129.00
-194.00
-176.00
Raw Materials Consumed
2,824.00
2,706.00
2,205.00
2,144.00
1,923.00
1,820.00
Power & Fuel Cost
351.00
333.00
283.00
242.00
207.00
201.00
Employee Cost
1,983.00
1,708.00
1,287.00
1,177.00
1,013.00
921.00
Operating Expenses
814.00
681.00
488.00
293.00
242.00
216.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
532.00
459.00
398.00
369.00
301.00
331.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
304.00
227.00
244.00
147.00
105.00
180.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
7,210.00
6,381.00
5,314.00
4,517.00
3,872.00
3,709.00
Operating Profit (PBDIT) excl Other Income
1,729.00
1,323.00
929.00
1,312.00
1,547.00
909.00
Other Income
92.00
124.00
125.00
66.00
62.00
67.00
Operating Profit (PBDIT)
1,821.00
1,448.00
1,055.00
1,379.00
1,610.00
976.00
Interest
87.00
140.00
48.00
11.00
12.00
19.00
Profit before Depriciation and Tax
1,734.00
1,307.00
1,006.00
1,368.00
1,598.00
957.00
Depreciation
397.00
357.00
261.00
232.00
209.00
210.00
Profit Before Taxation & Exceptional Items
1,336.00
950.00
745.00
1,135.00
1,388.00
746.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,131.00
842.00
745.00
1,135.00
1,388.00
738.00
Provision for Tax
343.00
313.00
253.00
224.00
240.00
135.00
Profit After Tax
787.00
529.00
491.00
910.00
1,148.00
611.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
4,899.00
4,404.00
4,036.00
3,247.00
2,209.00
1,731.00
Profit Available for appropriations
5,637.00
4,951.00
4,507.00
4,131.00
3,349.00
2,337.00
Appropriations
5,637.00
4,951.00
4,507.00
4,131.00
3,349.00
2,337.00
Equity Dividend (%)
400.00%
400.00%
400.00%
400.00%
400.00%
250.00%
Earnings Per Share
29.08
21.57
18.58
34.85
45.01
47.77
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 9.87% vs 8.29% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.71% vs 25.86% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -30.13% vs -46.92% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 74.03% vs 22.69% in Mar 2025

Compare Profit and Loss Results of Ipca Labs
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
8,939.00
0
8,939.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
8,939.00
0
8,939.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-46.00
0
-46.00
0%
Raw Materials Consumed
2,824.00
0
2,824.00
0%
Power & Fuel Cost
351.00
0
351.00
0%
Employee Cost
1,983.00
0
1,983.00
0%
Operating Expenses
814.00
0
814.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
532.00
0
532.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
304.00
0
304.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
7,210.00
0
7,210.00
0%
Operating Profit (PBDIT) excl Other Income
1,729.00
0.00
1,729.00
0%
Other Income
92.00
0
92.00
0%
Operating Profit (PBDIT)
1,821.00
0
1,821.00
0%
Interest
87.00
0
87.00
0%
Profit before Depriciation and Tax
1,734.00
0
1,734.00
0%
Depreciation
397.00
0
397.00
0%
Profit Before Taxation & Exceptional Items
1,336.00
0
1,336.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
1,131.00
0
1,131.00
0%
Provision for Tax
343.00
0
343.00
0%
Profit After Tax
787.00
0
787.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
4,899.00
0
4,899.00
0%
Profit Available for appropriations
5,637.00
0
5,637.00
0%
Appropriations
5,637.00
0
5,637.00
0%
Equity Dividend (%)
400%
0%
400.00
Earnings Per Share
29.08
0
29.08
0%
Profit And Loss - Net Sales
Net Sales 7,336.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.87% vs 8.29% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,782.24 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.71% vs 25.86% in Mar 2025

Profit And Loss - Interest
Interest 45.46 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -30.13% vs -46.92% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1,132.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 74.03% vs 22.69% in Mar 2025